Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04752501 · ClinicalTrials.gov registry record · NA

Maladaptive Psychosocial Beliefs and Adolescents With Patellofemoral Pain

A NA study, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT04752501: Completed NA study, sponsored by Nationwide Children's Hospital.

NCT04752501 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04752501, a NA study, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

This is a randomized prospective study assessing the impact of psychosocial factors on pain and physical performance among adolescents with patellofemoral pain. A set of psychosocial surveys assessing fear avoidance beliefs, kinesiophobia, and pain catastrophizing will be completed by the participant/parents. Participants will then complete an activity questionnaire, numeric pain rating scale, and a self-report questionnaire of functional ability. Participants will then be randomized into one of two groups (psychologically informed education group and a control group). Participants will view a series of educational videos (based upon group assignment) and complete physical therapy exercises for lower extremity strengthening, flexibility, and neuromuscular control. Participants with patellofemoral pain will then complete follow-up surveys of their psychosocial beliefs, pain and self-reported functional ability through REDcap at immediately post-intervention, 1 week, 3 weeks, 6 weeks, and 3 months.

Primary Outcome

Assessment of change of the Anterior Knee Pain Scale (AKPS). The AKPS is a self-reported 13 item questionnaire with discrete categories related to various levels of current knee function. Categories within each item are weighted, and responses are summed to provide an overall score of 0-100, with 100 representing no disability. The Anterior Knee Pain Scale is found to be valid and reliable in patients from 12-50 years of age presenting with anterior knee pain with a test-retest reliability of .9

Interventions

  • OTHER Psychologically Informed Education
  • OTHER Biomedical Education (Control)

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2021-03-08
Est. Completion 2022-08-10
Phase NA
Nationwide Children's Hospital

188 total trials

What the finished NCT04752501 record still lists

NCT04752501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Psychologically Informed Education is the first listed.

NCT04752501 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04752501 about?

NCT04752501 is a clinical study titled "Maladaptive Psychosocial Beliefs and Adolescents With Patellofemoral Pain". This is a randomized prospective study assessing the impact of psychosocial factors on pain and physical performance among adolescents with patellofemoral pain. A set of psychosocial surveys assessing fear avoidance beliefs, kinesiophobia, and pain catastrophizing will be completed by the participan...

What is the current status of trial NCT04752501?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2021-03-08. Estimated completion is 2022-08-10.

What interventions are being tested in trial NCT04752501?

The interventions under investigation include: Psychologically Informed Education (OTHER), Biomedical Education (Control) (OTHER).

Who is sponsoring clinical trial NCT04752501?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04752501's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04752501, the US trial registry maintained by the National Library of Medicine. NCT04752501 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.